Understanding the Genetic
Architecture of Parkinson's Disease

The Global Parkinson’s Genetics Program (GP2) is an ambitious program to genotype >150,000 volunteers around the world to further understand the genetic architecture of Parkinson’s disease (PD). There is still much to learn about genetic risk factors and the path to further understanding requires working collaboratively and openly sharing data, processes, and results.

View Progress

See how many samples are completed and shared with the AMP® PD platform for use.

Learn more

Submit a Cohort

Collaborate with us and submit a cohort to GP2. 

Get Started

GP2 Updates

Check out the latest news about GP2.

More Updates

GP2 Announces First Data Release

December 22, 2021
GP2 is excited to announce, in collaboration with AMP® PD, our first data release. It consists of 4,908 participants from multiple cohorts.

GP2 Launches Interactive Dashboard

December 20, 2021
Explore this tool to see our progress collecting diverse cohorts from around the world (updated quarterly).

GP2 Awards New Trainees

October 12, 2021
Professional development helps power the GP2 initiative. The demand for Parkinson’s disease (PD) genetics specialists is only growing, and GP2 provides opportunities and training to PD researchers from around the world to address this need. Their work and discoveries will form the basis for accelerating the path to a cure.

Latest Blog Posts

Read the latest blogs from GP2’s scientists and collaborators.

More Blogs

The Components of GP2’s Second Data Release

May 20, 2022
In April 2022, GP2 announced the second data release on the Terra platform in collaboration with AMP® PD. This release contains data from both complex and monogenic GP2 networks. The complex disease data now consists of a total of 8,644 genotyped participants (5,249 PD, 3,395 non-PD).

Surgicogenomics and Individuals with GBA Mutations

April 28, 2022
Benjamin Stecher and Alfonso Fasano discuss how using genetic information as a prognostic indicator might be relevant to assess surgical outcomes.

GP2 Celebrates the International Day of Women and Girls in Science

February 10, 2022
On the International Day of Women and Girls in Science, Sara Bandres-Ciga, Co-lead Training, Networking and Communication working group, shares how GP2 is working to empower women to lead, create and innovate in the field of PD genetics.

Working Groups

Find out about GP2’s working groups and their recently accomplished milestones.

View More